|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 152.77 USD | -6.97% |
|
-17.94% | -7.20% |
| 22/12 | Nutex Health Inc. Opens Archview ER & Hospital in St. Louis | CI |
| 04/12 | Nutex Health extends share repurchase plan | RE |
| Capitalization | 108.04Cr 93Cr 87Cr 81Cr 150.29Cr 9.8TCr 161.7Cr 997.36Cr 393.27Cr 4.68TCr 405.15Cr 396.81Cr 17TCr | P/E ratio 2025 * |
10.9x | P/E ratio 2026 * | 7.27x |
|---|---|---|---|---|---|
| Enterprise value | 108.04Cr 93Cr 87Cr 81Cr 150.29Cr 9.8TCr 161.7Cr 997.36Cr 393.27Cr 4.68TCr 405.15Cr 396.81Cr 17TCr | EV / Sales 2025 * |
1.1x | EV / Sales 2026 * | 1.06x |
| Free-Float |
60.95% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Nutex Health Inc.
More recommendations
More press releases
| 1 day | -6.97% | ||
| 1 week | -17.94% | ||
| Current month | -7.20% | ||
| 1 month | -11.04% | ||
| 3 months | +57.98% | ||
| 6 months | +46.78% | ||
| Current year | -7.20% |
| 1 week | 149 |  | 189.45 |
| 1 month | 146.82 | | 193.07 |
| Current year | 146.82 | | 192 |
| 1 year | 36.05 | | 193.07 |
| 3 years | 4.16 | | 268.5 |
| 5 years | 4.16 | | 7,920 |
| 10 years | 4.16 | | 7,920 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Vo
CEO | Chief Executive Officer | 53 | 01/04/2022 |
Jon Bates
DFI | Director of Finance/CFO | 56 | 30/06/2022 |
| President | 54 | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 01/04/2022 | |
Thomas Vo
CHM | Chairman | 53 | 01/04/2022 |
Cheryl Grenas
BRD | Director/Board Member | 66 | 01/04/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.85% | 0% | 2,091 M€ | |
| +5.41% | 0% | 7 M€ | |
| +2.78% | 0% | 31 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.97% | -17.94% | +303.51% | -40.44% | 108.04Cr | |
| -3.00% | -0.59% | +51.66% | +81.28% | 11TCr | |
| -3.39% | -2.12% | +51.27% | -12.59% | 9.98TCr | |
| +0.36% | +1.22% | +39.97% | +74.54% | 3.26TCr | |
| -0.46% | +4.73% | -10.99% | +17.50% | 2.42TCr | |
| +0.74% | +7.57% | +13.44% | +7.61% | 2.25TCr | |
| -0.40% | +8.63% | +24.94% | +28.09% | 2.11TCr | |
| -2.27% | -2.22% | +48.18% | +280.32% | 1.73TCr | |
| -0.17% | -2.28% | +50.81% | +54.04% | 1.65TCr | |
| -2.11% | -3.45% | +8.60% | +35.16% | 1.25TCr | |
| Average | -1.77% | -0.47% | +58.14% | +52.55% | 3.55TCr | |
| Weighted average by Cap. | -2.05% | +0.24% | +41.23% | +48.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 98Cr 85Cr 79Cr 73Cr 136.66Cr 8.91TCr 147.04Cr 906.91Cr 357.6Cr 4.25TCr 368.41Cr 360.83Cr 16TCr | 101.82Cr 88Cr 82Cr 76Cr 141.65Cr 9.24TCr 152.4Cr 939.99Cr 370.65Cr 4.41TCr 381.85Cr 373.99Cr 16TCr |
| Net income | 9.99Cr 8.61Cr 8.02Cr 7.46Cr 14Cr 906.44Cr 15Cr 92Cr 36Cr 432.37Cr 37Cr 37Cr 1.58TCr | 17Cr 14Cr 13Cr 12Cr 23Cr 1.5TCr 25Cr 152.56Cr 60Cr 715.25Cr 62Cr 61Cr 2.61TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
880
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 152.77 $ | -6.97% | 2,61,119 |
| 15/26/15 | 164.21 $ | -1.02% | 1,41,537 |
| 14/26/14 | 165.90 $ | -3.88% | 1,74,108 |
| 13/26/13 | 172.60 $ | -4.49% | 1,54,898 |
| 12/26/12 | 180.72 $ | -2.94% | 1,24,302 |
End-of-day quote Nasdaq, January 16, 2026
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
152.77USD
Average target price
250.00USD
Spread / Average Target
+63.64%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NUTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition